Gland Pharma appoints Shyamakant Giri as new CEOShyamakant Giri has been appointed as the new CEO of Gland Pharma, effective January 15, 2025. Giri brings over 25 years of experience in t...
18 Oct, 2024, 07.56 PM IST
US co Amneal plans units in India for weight-loss drugsAmneal Pharmaceuticals is set to invest $150-200 million over four to five years to build a manufacturing facility in Ahmedabad for weight ...
09 Oct, 2024, 12.13 AM IST
Amneal Pharmaceuticals to invest up to USD 200 mn in India to set up 2 new plantsAmneal Pharmaceuticals announces a significant investment of up to USD 200 million in India over the next four to five years. The funds wil...
08 Oct, 2024, 06.53 PM IST
Take advantage of Make in India in high-tech manufacturing: Piyush Goyal to US cosCommerce Minister Piyush Goyal invited American companies to invest in India's electronics, data infrastructure, and logistics sectors duri...
01 Oct, 2024, 10.36 PM IST
US drugmaker Amneal bets big on India formulation businessThe $2 billion company by revenue promoted by NRI entrepreneur brothers Chirag Patel and Chintu Patel, has begun commercial operations in I...
29 Nov, 2022, 04.59 PM IST
US drugmaker Amneal bets big on India's formulation marketThe drug maker even has plans to bring differentiated products based on novel drug delivery systems, biosimilars and specialty drugs from i...
29 Nov, 2022, 12.42 AM IST
19 Indian companies get licence to make Pfizer's oral genericThese include Cipla, Sun Pharma, Laurus Labs, Divi's Laboratories, Glenmark, Emcure, Macleods, SMS Pharmaceuticals, Strides, Torrent, Cadil...
18 Mar, 2022, 12.50 AM IST
Amneal Pharma to set up plant in GujaratThe NYSE-listed, $2-billion drug maker by sales (2020), which is foraying into India's domestic formulations segment with focus on biologic...
19 Nov, 2021, 06.59 AM IST
Amneal to enter Indian formulation mkt, to setup greenfield biologics plant in AhmedabadIn an interview to ET, Chirag Patel, Co-Chief Executive Officer of Amneal said that the company would hit the Indian market with its first ...
16 Nov, 2021, 08.15 PM IST
US-based Amneal Pharmaceuticals buys India's injectable maker Punishka Healthcare for Rs 700 croresAmneal Pharmaceuticals on Tuesday said it has acquired Ahmedabad-based injectable drug maker Puniska Healthcare Pvt. Ltd for a total value ...
10 Nov, 2021, 06.28 AM IST
Exit without serving notice period to attract 18% GST“We hold that the applicant is liable to pay GST at 18% under the entry of services not elsewhere classified, on recovery of notice pay fro...
13 Jan, 2021, 10.48 AM IST
Analyst Calls: Dr Reddy’s Lab, Sun Pharma, Voltas, RILNomura has a buy rating on Dr Reddy’s Laboratories with a target price of Rs 3,200.
17 Dec, 2019, 07.28 AM IST
Top stocks in focus on Friday, 1 September 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
01 Sep, 2017, 09.18 AM IST
Arrow Pharma acquires Australian operations of Amneal PharmaUnder the terms of the agreement, Arrow Pharmaceuticals will acquire 100 per cent of the issued capital of Amneal Pharmaceutical Pty Ltd Au...
31 Aug, 2017, 07.22 PM IST
Lupin launches Amabelz tablets in US marketThe company's product is indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause and pre...
15 Nov, 2016, 07.30 PM IST
UCB files cases against Ranbaxy, Aurobindo, Glenmark, Sun Pharma, others on patent issueUCB alongwith others has filed separate cases against as many as 15 drug makers for allegedly infringing its patented drug Vimpat.
22 Jul, 2013, 02.53 PM IST
- Indoco in JV to sell ophthalmic products in US
Indoco Remedies has formalised a joint venture agreement with New Jersey-based Amneal Pharmaceuticals to market 10 ophthalmic products in t...
22 Oct, 2007, 12.00 AM IST